Patient Information Leaflet (PIL)
Patient Information Leaflet (PIL) Services for Global Labeling SubmissionsAt Masuu Global, we specialize in creating comprehensive and compliant Patient Information Leaflet (PIL) tailored for global submissions. Our services ensure that pharmaceutical companies can effectively communicate critical information about their products to patients worldwide, promoting safe and informed medication use. Our expertise spans regulatory requirements set by major health authorities including the USFDA, EMA, Health Canada, TGA, SFDA, JFDA, and other global health authorities.
Our comprehensive PIL Services includes:- Design, Layout and PIL:
Designing PILs with a customer specific keyline line drawing (KLD) with using acceptable font type, font size and colours that enhances readability and accessibility. - Review and Approval Assistance:
Providing support throughout the review and approval process of labeling document, addressing any regulatory feedback promptly and effectively. - Post-Market Surveillance:
Monitoring regulatory changes and emerging safety information, ensuring that PILs are updated accordingly to reflect the lawww information. - Lifecycle Management:
Offering ongoing management of PIL content throughout the product lifecycle, ensuring continuous compliance and relevance.
- Expertise Across Major Markets:
Our deep understanding of regulations from USFDA, EMA, Health Canada, TGA, SFDA, JFDA, and other global health authorities ensures your PILs meet stringent global standards. - End-to-End Service:
From initial drafting to regulatory submission and post-approval updates, we provide a full spectrum of PIL services.
With Masuu Global, pharmaceutical companies can ensure their Patient Information Leaflet are not only compliant but also effectively communicate vital information to patients worldwide, supporting safe and informed medication use.
Frequently Asked Questions
A Patient Information Leaflet (PIL) is a document provided with a medicine that explains its purpose, dosage, possible side effects, precautions, and storage instructions in language patients can understand. It helps patients make informed decisions and use their medications safely. A well-prepared PIL also supports regulatory compliance and effective communication.
A PIL typically includes the medicine’s uses, dosage instructions, warnings, contraindications, possible side effects, storage conditions, and guidance on what to do if a dose is missed. The content must be accurate, clear, and easy to understand. Specific requirements depend on the product and the regulations of the target market.
Yes, Masuu Global supports the development and adaptation of PILs for various international markets. Our team considers the requirements of regulatory authorities such as the US FDA, EMA, Health Canada, TGA, SFDA, and JFDA. We help ensure that each leaflet meets applicable regulatory expectations while maintaining consistency in product information.
We focus on clear language, logical content organization, and readable formatting when developing PILs. Our team considers font type, font size, layout, and accessibility requirements to make essential information easier to locate and understand. This approach supports better patient awareness and safer medication use.
Yes, we provide PIL design and layout services, including customer-specific keyline drawings (KLDs). Our team ensures that the document follows the required formatting, font, and color specifications while maintaining readability. We also consider packaging constraints and regulatory requirements during the design process.
Masuu Global assists pharmaceutical companies throughout the PIL review and approval process. We review regulatory feedback, coordinate necessary revisions, and help ensure that the updated documents address the relevant authority’s requirements. Our support helps maintain accuracy and consistency during regulatory submissions.
A PIL should be reviewed and updated whenever new safety information, regulatory changes, or product-related developments affect its content. Updates may also be necessary when dosage instructions, warnings, precautions, or other approved product information changes. Timely revisions help maintain compliance and ensure patients receive accurate information.
Yes, we provide ongoing lifecycle management for PILs, including content revisions, regulatory updates, and post-approval changes. Our team monitors relevant developments and supports the implementation of necessary updates. This helps pharmaceutical companies maintain compliant and current patient information throughout the product lifecycle.
Professional PIL services help identify content gaps, formatting issues, and inconsistencies before submission. By ensuring that leaflets are accurate, readable, and aligned with regulatory requirements, companies can minimize avoidable review comments. This supports a more efficient submission process and helps maintain regulatory compliance.
Masuu Global offers end-to-end PIL support, from initial drafting and design to regulatory review assistance and post-approval lifecycle management. Our expertise across major international markets helps ensure that patient information is accurate, accessible, and compliant. We work closely with pharmaceutical companies to support safe medication use and successful global submissions.